STV-10, also known as Sativanol, is presented as a semi-synthetic neo-cannabinoid derived from CBD, reputed to have a significantly higher psychoactive potency than traditional CBD. Note: "STV-10" also refers to numerous industrial parts (vacuum cleaners, valves, connectors, etc.) in technical catalogs. It is essential to specify "cannabinoid" or "Sativanol" in any search to avoid confusion with these industrial uses. In France, its legal status remains uncertain: everything depends on the final composition of the product, particularly the Δ9-THC content, and its interpretation under the Public Health Code and European regulations. Before any purchase or use, a Certificate of Analysis (COA) issued by an independent laboratory is mandatory.
A practical warning is necessary from the outset: if you search for information on this new cannabinoid online, you will very often come across industrial parts bearing the same code. A Clarke STV-10 industrial vacuum cleaner, a Hynautic STV-10 shut-off valve for hydraulic circuits, or Weidmüller STV S 10 TS PCB connectors appear at the top of the results. Always add "cannabinoid" or "Sativanol" to your search to obtain relevant results.
General information only. This article does not constitute medical, legal, or pharmaceutical advice. Consult a healthcare professional or legal advisor before use or purchase.
Key points
STV-10 (Sativanol) is a semi-synthetic neo-cannabinoid with reported high potency whose legal status in France remains uncertain, which requires verification of the COA, compliance with the Δ9-THC threshold and medical consultation before any use.
| Point | Details |
|---|---|
| Correct identification | Specify "Sativanol cannabinoid" in your searches; the code STV-10 also designates unrelated industrial parts. |
| COA verification required | Demand a recent COA from an ISO 17025 accredited third-party laboratory, with a complete cannabinoid profile and contaminant tests. |
| Cautious dosage | Start with the minimum dose and wait at least 2 hours before any reassessment, especially if taken orally. |
| Uncertain legal framework | The legal status depends on the Δ9-THC content and the interpretation of the authorities; consult a lawyer if in doubt. |
| Lord Of CBD as an alternative | Lord Of Cbd offers compliant CBD products (THC < 0.3%), with accessible analyses and personalized advice. |
Table of Contents
- What is STV-10 from a chemical standpoint?
- What effects are reported with STV-10?
- STV-10 compared to CBD, HHC, THCP and Δ9-THC: where does it stand?
- In what forms is the STV-10 available on the French market?
- What is the legal status of the STV-10 in France and Europe?
- What are the risks and contraindications to be aware of?
- How can I check the quality of an STV-10 product before buying it?
- What do we really know about the STV-10 from a scientific point of view?
- Our editorial view on the STV-10
- Controlled alternatives: what Lord Of Cbd offers
- Sources
What is STV-10 from a chemical standpoint?
STV-10 belongs to the neo-cannabinoid family, a category of molecules obtained through controlled chemical modification of natural cannabinoids such as CBD. The starting precursor is usually cannabidiol extracted from hemp, on which targeted molecular transformations modify the side chain or cyclic structure to increase affinity for endocannabinoid receptors.
The general steps of the process involve:
- CBD extraction from industrial hemp (supercritical CO₂ or ethanol)
- Chemical modification of the side chain or molecular nucleus in the laboratory
- Purification by chromatography to isolate the target molecule
- Analytical testing (HPLC, GC-MS) to verify purity and the absence of undesirable by-products
- Enrichment of a support (flower, resin, e-liquid) with the molecule obtained
This transformation increases the molecule's lipophilicity and, according to available data, its affinity for the CB1 and CB2 receptors of the endocannabinoid system. This is precisely what explains the reported potency. Without a recent Certificate of Authenticity (COA) from a third-party laboratory, it is impossible to verify the exact nature of the molecule present in a product sold under this name. To understand the basics of this process, Lord Of CBD's page on CBD manufacturing offers a good starting point.
The terminological confusion online is real: the code "STV-10" refers to both a Rasmussen control valve and components listed under NSN 4820-01-621-4941 in military and industrial catalogs. The Weidmüller catalog also lists several "STV" variants for electronic connectors. Specifying "Sativanol cannabinoid" in your searches is not optional, it's essential.
What effects are reported with STV-10?
User feedback describes a rather stimulating profile: increased mental clarity, mild euphoria, creativity, and a sense of well-being. At higher doses, adverse effects appear, including anxiety, tachycardia, and, in some cases, disorientation. This data remains anecdotal due to a lack of published clinical studies.
The presumed mechanism relies on a more pronounced modulation of CB1 (primarily found in the brain) and CB2 (immune system, peripheral tissue) receptors compared to CBD, which has a low affinity for these receptors. A stronger CB1 affinity produces more pronounced psychoactive effects, which fundamentally distinguishes STV-10 from regular CBD.
Typical temporal profile reported (inhaled route):
- Onset : 2 to 10 minutes after inhalation
- Peak : 20 to 45 minutes
- Plateau : 1 to 2 hours depending on the dose and individual tolerance
- Gradual descent : 2 to 4 additional hours
When taken orally (gummies, oil), the onset is slower (30 to 90 minutes) and the total duration can reach 6 hours, with an intensity that is sometimes difficult to anticipate.
Pro tip: Always start with the lowest possible dose and wait at least 2 hours before considering taking more, especially orally. Drug interactions are possible, particularly with anticoagulants, benzodiazepines, and CYP450 inhibitors; consult a doctor if you are taking regular medication.
STV-10 compared to CBD, HHC, THCP and Δ9-THC: where does it stand?
Placing STV-10 in the cannabinoid landscape helps to understand why more caution is required than with a simple CBD product.
- CBD : non-psychoactive, low CB1 affinity, documented relaxing and anxiolytic effects, legal in France under certain conditions (THC < 0.3%)
- HHC : mildly psychoactive, moderate CB1 affinity, mild euphoric effects, legal status in France contested since 2023
- Δ9-THC : a reference psychoactive substance with a strong affinity for CB1 receptors, classified as a narcotic in France when exceeding the legal threshold.
- THCP : THC analogue with an elongated side chain, estimated to have very high CB1 affinity, intense effects reported
- STV-10 (Sativanol) : semi-synthetic neo-cannabinoid, CB1 affinity reported to be superior to CBD and HHC, stimulant profile, potency comparable to some THC analogues depending on the dosage.
Caution: Increased potency does not mean increased safety. The stronger the CB1 affinity, the higher the risk of adverse psychological (anxiety, paranoia, depersonalization) and cardiovascular effects, particularly for individuals without prior tolerance, minors, pregnant women, and those with psychiatric disorders.
In what forms is the STV-10 available on the French market?
The commercial formats observed for STV-10 enriched products are varied, and each route of administration significantly alters the risk profile.
- Enriched flowers : CBD hemp flowers vaporized or smoked after enrichment with STV-10
- Resins and concentrates : enriched BHO or rosin resins, consumed in a pipe or vaporizer
- E-liquids and vape cartridges : ready-to-vape solution, rapid onset, dosage difficult to control
- Gummies and edibles : oral ingestion, delayed and prolonged effect, risk of accidental overdose
- Sublingual oils : rapid absorption under the tongue, intermediate profile between inhalation and ingestion
| Administrative route | Action deadline | Estimated duration | Relative risk level |
|---|---|---|---|
| Inhalation (vape/flower) | 2–10 min | 2–4 h | High (rapid onset, difficult to dose) |
| Sublingual (oil) | 20–45 min | 3–4 h | Moderate |
| Oral (gummies/edibles) | 30–90 min | 4–8 h | High (delayed effect, risk of redosing) |
| Resin/concentrate | 2–10 min | 2–4 h | Very high (variable concentration) |
The variability in dosage between formats is considerable. A product enriched by hand can contain very different concentrations from batch to batch. Only a recent Certificate of Analysis (COA), with a complete cannabinoid profile, allows us to know the actual content.
What is the legal status of the STV-10 in France and Europe?
The legal status of the STV-10 in France is uncertain and depends on several simultaneous factors, making it one of the most delicate points for a buyer to assess.
Legal summary: No French or European legislation explicitly names STV-10 (Sativanol) as a controlled substance to date. However, if a product contains Δ9-THC above the legal threshold (0.3% in France for hemp-derived products), or if the molecule is classified as a narcotic analogue by the authorities, the legal risks become real. The Public Health Code and the lists of controlled substances are regularly updated.
The relevant rules to know:
- Δ9-THC threshold : In France, hemp-derived products must contain less than 0.3% Δ9-THC to be legal; this threshold applies to the plant, but its interpretation for semi-synthetic derivatives remains unclear.
- Distinction between hemp and synthetic products : a neo-cannabinoid obtained through chemical modification is not automatically covered by the exemptions applicable to natural hemp.
- European law : the EFSA Novel Food Regulation and the directives on psychoactive substances may apply depending on the commercial form
- Risk of misinterpretation : French authorities (ANSM, customs) may classify a product as a narcotic analogue even in the absence of explicit listing.
Pre-purchase checklist:
- Recent COA (less than 6 months old) from a third-party accredited laboratory
- Δ9-THC content clearly indicated and less than 0.3%
- Documented botanical origin of the CBD precursor
- Full legal information on the label (manufacturer, batch, date)
- Absence of contaminants (residual solvents, heavy metals, pesticides)
To delve deeper into the legal framework surrounding CBD in France, guide to CBD legality remains a useful resource. For importing, reselling, or any serious doubts, consult a specialized legal advisor.
What are the risks and contraindications to be aware of?
The reported potency of STV-10 implies greater risks than those associated with CBD. Here are the main ones:
- Acute risks : intense anxiety, palpitations, tachycardia, nausea, disorientation, panic attacks
- Risks with repeated use : possible psychological dependence, increased tolerance, sleep disturbance
- Impaired driving ability : Driving and operating machinery are not recommended during and after consumption
- Legal risk : possible positive result on saliva tests depending on the product's composition
Groups at absolute or relative risk:
- Pregnant or breastfeeding women
- People suffering from psychiatric disorders (schizophrenia, bipolar disorder, history of psychosis)
- People with cardiovascular disease
- Minors
- People undergoing regular medication
| Drug class | Risk of interaction |
|---|---|
| Anticoagulants (warfarin, rivaroxaban) | Potentiation possible, risk of bleeding |
| Benzodiazepines / anxiolytics | Increased sedation, respiratory depression |
| CYP450 inhibitors (certain antifungals, antiretrovirals) | Increased plasma concentrations |
| Antipsychotics | Unpredictable pharmacodynamic interaction |
| Antidepressants (SSRIs) | Risk of serotonin syndrome to monitor |
Always keep the Certificate of Analysis (COA) for the product used. In case of adverse effects, this document facilitates medical care.
How can I check the quality of an STV-10 product before buying it?
A COA (Certificate of Analysis) is not just a marketing document: it's the only verifiable proof of what a product actually contains. Here's how to evaluate it.
Product quality checklist:
- The COA is issued by an accredited third-party laboratory (ISO 17025 or equivalent), not by the manufacturer itself
- The analysis date is recent (less than 6 months for products in stock)
- The complete cannabinoid profile is listed (CBD, CBG, CBN, Δ9-THC, Δ8-THC, and the STV-10/Sativanol molecule if identifiable)
- The detection limits are indicated for each analyte
- Contaminants are tested for: residual solvents, heavy metals (lead, cadmium, mercury), pesticides, mycotoxins
- The batch number on the COA exactly matches the one printed on the packaging
| COA field | What you need to check |
|---|---|
| Method of analysis | HPLC or GC-MS for cannabinoids; ICP-MS for metals |
| Date of issue | Less than 6 months |
| Signature and accreditation | Laboratory accreditation number visible |
| Cannabinoid profile | All molecules listed with concentrations in % or mg/g |
| Contaminants | "Pass/fail" results with numerical values |
Safe usage tips:
- "Start low, go slow" protocol: begin with the minimum indicated dose
- Keep a dosage log (dose, time, effects felt)
- Do not drive or operate machinery for at least 6 hours after consumption
- Keep products out of reach of children, away from heat and light
Pro tip: To verify the authenticity of a Certificate of Analysis (COA), note the lot number and contact the issuing laboratory directly by phone or email to confirm that the lot was indeed analyzed. A reputable laboratory will respond to this request without difficulty.
To choose a reliable supplier, the selection criteria for a CBD supplier detailed by Lord Of Cbd provide a solid framework for understanding.
What do we really know about the STV-10 from a scientific point of view?
Data available on STV-10 is currently very limited. No clinical studies published in a peer-reviewed journal specifically address this molecule. Information circulating online comes primarily from marketing materials, user testimonials, and extrapolations from research on structurally similar cannabinoids.
What science can tell us today: Semi-synthetic neo-cannabinoids derived from CBD share presumed mechanisms of action with natural cannabinoids, but their pharmacokinetics, long-term toxicology, and drug interactions remain largely unknown. Interpreting user testimonials as evidence of efficacy or safety would be a serious methodological error.
Types of evidence available:
- Preclinical data on structurally similar cannabinoids (in vitro, animal models)
- User testimonials (anecdotal, unverified)
- Manufacturers' trade reports (obvious bias)
What's missing:
- Randomized clinical trials on safety and efficacy
- Human pharmacokinetic studies (absorption, distribution, metabolism, elimination)
- Long-term toxicology data
- Studies on drug interactions
- Documented profiles of addiction and withdrawal
Caution in interpreting opinions on the STV-10 is not excessive conservatism: it is the only stance consistent with the actual state of knowledge.
Our editorial view on the STV-10
The debate surrounding neo-cannabinoids like STV-10 reveals a tension that the French CBD market has not yet resolved: the growing demand for potency from some consumers is met with a regulatory vacuum that poorly protects these same consumers.
What strikes me is that the public conversation surrounding these molecules is replicating the exact same mistakes made with HHC in 2022 and 2023: early enthusiasm, a lack of reliable data, and then a late and disorganized regulatory response. STV-10 is following the same trajectory. Serious vendors know this, and the best among them admit it.
Some reputable sellers only offer products with verifiable compliance, containing less than 0.3% THC, sourced from selected producers, and with readily available analyses. This isn't a marketing ploy; it's an operational requirement that few online stores truly embrace. If you have any questions about a product's composition or the available analyses, the team can be reached via the contact page.
Controlled alternatives: what Lord Of Cbd offers
If you are interested in potency but are held back by the legal and health uncertainties surrounding STV-10, Lord Of Cbd offers a selection of premium CBD flowers and resins, each batch of which is accompanied by independent analyses and whose Δ9-THC content remains below 0.3%, in accordance with French regulations.
The available products cover the most popular formats: CBD-enriched flowers, concentrated resins, dosed oils, and e-liquids. The selection is based on rigorously vetted producers, with Certificates of Analysis (COAs) available before purchase. For personalized advice on the format or concentration best suited to your needs, contact the Lord Of CBD team directly.
Sources
To further investigate before purchasing or using a product containing STV-10, here are the most relevant resources:
- Buy STV-10 From Hynautic Inc with NSN (4820-01-621-4941)
- 1612640000STV S 10 LS90 | Weidmüüller Product Catalog
- Rasmussen STV-10 Manual Control Valve – US Fireplace Store
This article provides general information and is not a substitute for professional medical advice. Consult a qualified healthcare professional about your specific situation before taking any action based on this content.
Recommendation
- STV-10: Everything You Need to Know About This Ultra-Powerful Legal Neo-Cannabinoid – Lord Of CBD
- THV-N10: What Is It and Why Lord Of CBD's CRD Is a Better Legal Alternative – Lord Of CBD
- Legal Cannabinoids in France: What Will Be Allowed in 2026
- 10-OH-THC: Effects, Properties, and Differences with 11-OH-THC | Everything You Need to Know – Lord Of CBD